A pharmaceutical-grade version of nicotine known as Nicotine Polacrilex USP/EP is frequently included in smoking cessation products and nicotine replacement therapy (NRTs). The quality, purity, and safety of this formulation for use in medicine are guaranteed by its adherence to the criteria specified by the European Pharmacopoeia (EP) and the United States Pharmacopeia (USP). Polacrilex USP/EP, a nicotine product, helps smokers reduce cravings and withdrawal symptoms by providing a regulated and steady release of nicotine in the form of gums, lozenges, and patches. Healthcare providers and patients can feel confident in Nicotine Polacrilex USP/EP's effectiveness and dependability because of its pharmaceutical-grade purity and consistency.